# Travere Therapeutics, Inc. (TVTX) stock price

URL: https://funkfolio.com/stock/TVTX

> Travere Therapeutics, Inc. (TVTX) trades at $51.10, is worth $4.91B and scores 41/100. Valuation, financials and signals.

---

## Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics, Inc. (TVTX) is a healthcare company (biotechnology) based in the United States. The share price is $51.10, up 2.82% on the day, which values the company at $4.91B. Price as of 17 Nov 2026, 21:48 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $51.10 +2.82% today
- **Market value:** $4.91B
- **Forward P/E:** 9.4×
- **Funk Score:** 41/100
- **Against its own history:** Well above its usual price usual price $19.23
- **200-week average:** $22.94 123% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 21:48 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Travere Therapeutics, Inc. in more detail

TVTX trades at 9.4× next year's expected earnings, 7.5× sales. Measured against its own history, the price is 166% above what its usual multiples would imply ($19.23) — well above its usual price. It sits 123% above its 200-week average of $22.94.

Over the last five fiscal years Travere Therapeutics, Inc. has compounded revenue 19.9% a year. Its Funk Score is 41 out of 100 (financial strength 5.6, profitability 2.0, growth 8.6, value 0.0, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Beneish M-score flags the accounts; Share count keeps rising.

1 of the superinvestors tracked here hold TVTX, including Polen Capital team (0.0% of the portfolio).

### Superinvestors holding TVTX

1 of the investors tracked here report a position in their latest 13F filing.

- [Polen Capital team Polen Capital Management](https://funkfolio.com/gurus/polen-capital) 0.03% of portfolio · $3.1M · added · Q3 2026

### Health Care companies of similar size

- [Merit Medical Systems MMSI](https://funkfolio.com/stock/MMSI)
- [Edgewise Therapeutics EWTX](https://funkfolio.com/stock/EWTX)
- [LivaNova LIVN](https://funkfolio.com/stock/LIVN)
- [Ionis Pharmaceuticals IONS](https://funkfolio.com/stock/IONS)
- [Dianthus Therapeutics DNTH](https://funkfolio.com/stock/DNTH)
- [MiniMed Group MMED](https://funkfolio.com/stock/MMED)
- [Adaptive Biotechnologies ADPT](https://funkfolio.com/stock/ADPT)
- [Heartflow HTFL](https://funkfolio.com/stock/HTFL)
- [CRISPR Therapeutics CRSP](https://funkfolio.com/stock/CRSP)
- [Option Care Health OPCH](https://funkfolio.com/stock/OPCH)
- [Legend Biotech LEGN](https://funkfolio.com/stock/LEGN)
- [Definium Therapeutics DFTX](https://funkfolio.com/stock/DFTX)

Side by side: [TVTX vs CRSP (Travere Therapeutics, Inc. vs CRISPR Therapeutics)](https://funkfolio.com/compare/crsp-vs-tvtx) [TVTX vs HTFL (Travere Therapeutics, Inc. vs Heartflow)](https://funkfolio.com/compare/htfl-vs-tvtx) [TVTX vs ADPT (Travere Therapeutics, Inc. vs Adaptive Biotechnologies)](https://funkfolio.com/compare/adpt-vs-tvtx) [TVTX vs OPCH (Travere Therapeutics, Inc. vs Option Care Health)](https://funkfolio.com/compare/opch-vs-tvtx) [TVTX vs MMED (Travere Therapeutics, Inc. vs MiniMed Group)](https://funkfolio.com/compare/mmed-vs-tvtx)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Travere Therapeutics, Inc. (TVTX): questions and answers

**What is Travere Therapeutics, Inc.'s market cap?**

Travere Therapeutics, Inc. is valued at $4.91B at a share price of $51.10.

**Is TVTX overvalued or undervalued?**

Against its own history, TVTX is well above its usual price: the price is 166% above the $19.23 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is TVTX above its 200-week moving average?**

Yes. TVTX is 122.8% above its 200-week average of $22.94. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Travere Therapeutics, Inc. growing?**

Over the last five fiscal years Travere Therapeutics, Inc.'s revenue grew 19.9% a year; over ten years revenue grew 17.3% a year.

**Does TVTX pay a dividend?**

Travere Therapeutics, Inc. does not currently pay a regular dividend.

**Which famous investors own TVTX?**

In their latest quarterly filings, Polen Capital team (0.0% of the portfolio) hold TVTX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Travere Therapeutics, Inc. (TVTX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TVTX

Underlying data: Yahoo Finance; company filings with the SEC.
